Peer-reviewed veterinary case report
Treatment options for feline atopic syndrome explained
By R. Mueller et al.·Published in Veterinary dermatology (Print)·2021·View original on Semantic Scholar →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Treatment of the feline atopic syndrome - a systematic review.
- Species:
- cat
Plain-English summary
A cat with allergic skin issues and asthma may benefit from various treatments. Research shows that systemic medications like glucocorticoids and ciclosporin are effective for managing feline atopic syndrome (FAS), which causes itchy skin. For asthma, both oral and inhaled glucocorticoids also work well. Other treatments like topical glucocorticoids, antihistamines, and immunotherapy have limited effectiveness. If your cat is struggling with allergies or asthma, discussing these treatment options with your veterinarian could help improve their comfort and health.
People also search for: cat itchy skin treatment · feline asthma medication · glucocorticoids for cats · cat allergy management · ciclosporin for cats
Abstract
BACKGROUND Feline allergic skin disease and asthma occur regularly in small animal practice. OBJECTIVES To provide evidence-based recommendations for small animal practitioners on the treatment of feline atopic syndrome (FAS). METHODS AND MATERIALS The authors reviewed the literature available before February 2020, prepared a detailed evidence-based literature review and made recommendations based on the evaluated evidence. RESULTS Sixty-six papers and abstracts were identified describing treatment interventions for FAS and evaluated to establish treatment recommendations. For many treatment options, the papers were retrospective, open studies or case reports. CONCLUSION AND CLINICAL RELEVANCE In this review, there was good evidence for the efficacy of systemic glucocorticoids and ciclosporin, and limited evidence for the efficacy of topical glucocorticoids, oclacitinib and allergen-specific immunotherapy in feline atopic skin syndrome. Evidence pointed to low-to-moderate efficacy for antihistamines, fatty acids and palmitoyl ethanolamide. In feline asthma, there was good evidence for the efficacy of oral and inhaled glucocorticoids, and limited evidence of moderate efficacy for allergen-specific immunotherapy. Evidence supported low-to-moderate efficacy of mesenchymal stem cells, inhaled lidocaine and oclacitinib as treatments for feline asthma. For almost all therapeutic options (with the exception of glucocorticoids and ciclosporin), more randomised controlled trials are needed.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on Semantic Scholar: https://www.semanticscholar.org/paper/33470011